Keywords: SkyePharma, Chief executive, Flutiform, Bronchodilator, Edison Investment Research

Two hurdles to jump for SkyePharma, as it changes CEO

Article | 31 January 2012

Print This

On the same day that UK-based SkyePharma (LSE: SKP) announced that Axel Mueller has resigned as chief executive and as ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in